BTIG Reiterates Buy Rating on Boston Scientific (BSX)

Boston Scientific (BSX) PT Raised to $78 at Deutsche Bank

Deutsche Bank analyst Pito Chickering raised the price target on Boston Scientific (NYSE: BSX) to $78.00 (from $73.00) while maintaining a Hold rating.

The analyst comments "All told, Boston continues to execute at a high level, with continued portfolio shift to higher-growth segments (WAMGR has increased to HSD from LSD historically), leaving the... More

Boston Scientific (BSX) PT Raised to $90 at Jefferies

Jefferies analyst Matthew Taylor raised the price target on Boston Scientific (NYSE: BSX) to $90.00 (from $82.00) while maintaining a Buy rating.

The analyst comments "BSX reported 2Q24 sales of $4.12B, +14.7% organic, vs cons $4.02B and EPS of $0.62 +17%. vs cons $0.58. BSX increased '24 guidance to... More

Boston Scientific (BSX) PT Raised to $82 at Evercore ISI

Evercore ISI analyst Vijay Kumar raised the price target on Boston Scientific (NYSE: BSX) to $82.00 (from $81.00) while maintaining a Outperform rating.

The analyst comments "Thesis Update: BSX reported an overall organic growth of ~14.7% and EPS growth of ~16%...while these are numbers that any company can be proud of, BSX shares are down -3% as we write this. We would notch the share reaction to the expectations game, which seems a little odd to us given that consensus trades have worked so far (ISRG up DD on hitting buyside expecs for systems).... More

Midday movers: Tesla, Alphabet, Visa fall; AT&T, Texas Instruments rise

(Updated - July 24, 2024 11:10 AM EDT)

Investing.com -- U.S. stock futures fell Wednesday, with disappointing results from a couple of tech giants hitting sentiment in the early days of the new earnings season.

Here are some of the biggest U.S. stock movers today:

Tesla (NASDAQ: TSLA) stock slumped 12% after the electric vehicle manufacturer after its second-quarter earnings missed estimates amid falling vehicle sales, and profit margins fell to a five-year... More

Citi Reiterates Buy Rating on Boston Scientific (BSX), Top Pick

Citi analyst Joanna Wuensch reiterated a Buy rating and $90.00 price target on Boston Scientific (NYSE: BSX).

The analyst comments "BSX delivered a strong 2Q24 results ahead of expectations with revenue of $4.12B (up 14.7% organic, ahead of consensuss $4.02B). The beat was broad based,... More

Boston Scientific (BSX) Tops Q2 EPS by 4c; offers guidance

Boston Scientific (NYSE: BSX) reported Q2 EPS of $0.62, $0.04 better than the analyst estimate of $0.58. Revenue for the quarter came in at $4.12 billion versus the consensus estimate of $4.02 billion.

GUIDANCE:

Boston Scientific sees Q3 2024 EPS of $0.57-$0.59, versus the consensus of... More

Alphabet/Tesla, Harris leads a poll, European earnings - what's moving markets

Investing.com -- Wall Street looks set to open on a negative note Wednesday, with second-quarter results from tech giants Alphabet (NASDAQ: GOOGL) and Tesla underwhelming. The U.S. political situation remains volatile, while the Eurpean earnings season hits top gear  

Alphabet (NASDAQ: GOOG) and Tesla (NASDAQ: TSLA) have started the ball rolling, in terms of the market-leading mega caps reporting, and investors were left... More

Boston Scientific (BSX) call put ratio 1.3 calls to 1 put into quarter results

Boston Scientific (NYSE: BSX) August call option implied volatility is at 30, September is at 24; compared to its 52-week range of 16 to 33 into the expected release of quarter results before the bell on July 24.

Boston Scientific (BSX) call put ratio 11.5 calls to 1 put with focus on August 85 calls

Boston Scientific (NYSE: BSX) July weekly 77.50 straddle priced for a move of 7% into the expected release of quarter results before the bell on July 24.